Registry for patients undergoing TIPS implantation for portal hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data from patients with clinically significant portal hypertension who are scheduled for transjugular intrahepatic portosystemic shunt (TIPS) implantation at the University Medical Center Freiburg. Patients will be assessed for clinical, laboratory, and outcome parameters before and up to 12 months after the procedure. Additionally, serum/plasma samples and peripheral blood mononuclear cells will be collected for biobanking. The study aims to evaluate the outcomes related to TIPS implantation, including complications and the need for further interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension

Exclusion Criteria:

* Withdrawal of written informed consent

Where it's running

• University Medical Center Freiburg, Department of Medicine II
  Freiburg im Breisgau, Germany Recruiting

Study contacts

• Principal investigator: Dominik Bettinger, MD — University Hospital Freiburg
• Study coordinator: Dominik Bettinger, MD
• Email: dominik.bettinger@uniklinik-freiburg.de
• Phone: 49761270-36870

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting liver failure after surgery in patients with chronic liver disease

  This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.

  Recruiting University Hospital, Bonn · Bonn · NCT04578301

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Austrian PBC Registry

  This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.

  Recruiting Medical University of Vienna · Klagenfurt, Carinthia and 10 other locations · NCT07598669

• Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis

  This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.

  Recruiting Phase 4 Asian Institute Of Medical Sciences · Hyderābād, Sindh · NCT07521332

• Blood clotting and portal vein changes during TIPS placement in cirrhosis

  This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.

  Recruiting Assistance Publique - Hôpitaux de Paris · Villejuif · NCT07439939

• Comparing HVPG and endoscopic ultrasound portal pressure measurements

  This study will test whether an endoscopic ultrasound method (EUS-PPG) gives the same portal pressure readings as the standard hepatic venous pressure gradient (HVPG) in adults who need portal pressure measurement.

  Recruiting at 2 sites Military University Hospital, Prague · Prague, Bohemia and 1 other locations · NCT07424963

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.